Biomarkers to earlier recognize Bone Metastases
Dresden, 18.12.2018
A team of bone and cancer specialists from Essen and Dresden have identified two biomarkers (RANKL and OPG) in a study of bone metabolism that can better predict the course of breast cancer over a ten-year period. The team hopes that the discovery will lead to a more precise risk assessment regarding personalized therapies, with the aim of delaying the progression of the disease. The results of their study were published in the journal Clinical Cancer Research (doi: 10.1158 / 1078-0432.CCR-18-2482).